Lista de obras -

A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores.

artículo científico publicado en 2017

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

artículo científico publicado en 2010

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients

artículo científico publicado en 2015

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

artículo científico publicado en 2015

Antibodies Reactive to Rickettsia rickettsii Among Children Living in the Southeast and South Central Regions of the United States ⬇️

artículo científico publicado el 1 de mayo de 2003

Assessing Modeled CO(2) Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants

artículo científico publicado en 2012

Challenges and opportunities in developing respiratory syncytial virus therapeutics

artículo científico publicado en 2015

Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus

artículo científico publicado en 2005

Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons

artículo científico publicado en 2017

Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification

artículo científico publicado en 2012

Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics

artículo científico publicado en 2017

Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults

artículo científico publicado en 2015

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants

artículo científico publicado en 2016

Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis

artículo científico publicado en 2005

Group B streptococcal ventriculitis: a report of three cases and literature review

artículo científico publicado en 2006

HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection

artículo científico publicado en 2013

Human genetic factors and respiratory syncytial virus disease severity

artículo científico publicado en 2008

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

artículo científico publicado en 2017

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

artículo científico publicado en 2015

Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.

artículo científico publicado en 2014

Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

artículo científico publicado en 2014

N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site

artículo científico publicado en 2010

Passive antibody prophylaxis for RSV.

artículo científico publicado en 2008

Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease

artículo científico publicado en 2003

Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor

artículo científico publicado en 2017

Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus (RSV) infected infants.

artículo científico publicado en 2017

RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy

scientific article published on 08 June 2009

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction

artículo científico publicado en 2014

Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus

artículo científico publicado en 2014

Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children

artículo científico publicado en 2015

Respiratory Mucosal Proteome Quantification in Human Influenza Infections

artículo científico publicado en 2016

Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.

artículo científico publicado en 2015

Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children ⬇️

artículo científico publicado el 1 de octubre de 2011

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis

artículo científico publicado en 2015

Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus

artículo científico publicado en 2014

Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

artículo científico publicado en 2006

SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

artículo científico publicado en 2016

SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

artículo científico publicado en 2019

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

artículo científico publicado en 2017

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

artículo científico publicado en 2014

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants

artículo científico publicado en 2004

The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, versus its achievable concentrations in the human respiratory tract and comparison to ribavirin.

artículo científico publicado en 2017

The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses

artículo científico publicado en 2012

Vaccination strategies against respiratory syncytial virus

scientific article published on 31 October 2016

Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants

artículo científico publicado en 2015

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

artículo científico publicado en 2010

Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure

artículo científico publicado en 2014

Lista de obras de

A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores.

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

Antibodies Reactive to Rickettsia rickettsii Among Children Living in the Southeast and South Central Regions of the United States ⬇️

Assessing Modeled CO(2) Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants

Challenges and opportunities in developing respiratory syncytial virus therapeutics

Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus

Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons

Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification

Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics

Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants

Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis

Group B streptococcal ventriculitis: a report of three cases and literature review

HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection

Human genetic factors and respiratory syncytial virus disease severity

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.

Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site

Passive antibody prophylaxis for RSV.

Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease

Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor

Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus (RSV) infected infants.

RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction

Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus

Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children

Respiratory Mucosal Proteome Quantification in Human Influenza Infections

Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.

Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children ⬇️

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis

Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus

Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants

The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, versus its achievable concentrations in the human respiratory tract and comparison to ribavirin.

The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses

Vaccination strategies against respiratory syncytial virus

Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure